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severely limited use of cattle and buffalo for 
traction, which is of major importance to the 
livelihoods of poor farmers.
CLINICAL DIAGNOSIS 
Clinical signs of FMD vary widely between 
species. In cattle, onset of FMD is usually 
characterized by pyrexia, anorexia and 
sometimes shivering, followed by smacking 
of the lips, grinding of the teeth, drooling, 
lameness and stamping or kicking of the 
feet. These symptoms are caused by vesicles 
on the buccal and nasal mucous membranes 
and /or between the claws and coronary 
band that will rupture, leaving erosions 
(OIE, 2009). Recovery generally occurs 
within 8-15 days although complications 
can include superinfection of lesions with 
bacteria or screw-worm infestation, hoof 
deformation, myocarditis, abortion, death 
of young animals and permanent loss of 
weight. Post mortem lesions on rumen 
pillars and in the myocardium, particularly 
in young animals (tiger heart), may be 
evident. In sheep and goats, the lesions are 
less pronounced and foot lesions may go 
unnoticed. Pigs may develop severe foot 
lesions, particularly when housed on 
concrete, and there may be high mortality in 
piglets (OIE, 2009). The differential 
diagnosis is species dependent and includes 
vesicular stomatitis, swine vesicular disease 
and vesicular exanthema of swine, which 
are all clinically indistinguishable from 
FMD. In view of the differentials, a sound 
laboratory based diagnosis is therefore a 
confirmatory tool in the diagnosis of FMD.
 
SUMMARY
Foot and mouth disease (FMD) is a major trans-boundary 
animal disease (TAD) that has a great potential for 
causing severe economic loss in susceptible cloven-hoofed 
animals. This paper describes the various diagnostic tests 
available for FMD, the limitations of each and their 
potential application in a low technology setting. The need 
to have complementary field and laboratory operations 
including suitable samples and transport methods are 
discussed, and examples are given. The importance of a 
quality assurance system to assess the accuracy and 
precision of diagnostic results is highlighted.
Keywords: Foot and mouth disease, Transboundary, 
Diagnostic tests, Quality assurance.
INTRODUCTION
Livestock is very important in the 
agriculturally based, resource poor 
economies and social structures of sub-
Saharan Africa. Endemic and periodically 
epidemic foot and mouth disease (FMD) has 
serious impact on food security (including 
crop production through its effect on 
draught animals), rural income generation 
and national economies by impairing 
livestock trade. Consequently, the poorest 
sectors of the community are most seriously 
affected. The progressive control of FMD is 
both a national priority and regional 
imperative (Khounsy et al., 2008). FMD is 
the most contagious disease of mammals 
and can cause severe economic losses in 
susceptible cloven-hoofed animals. While 
the disease usually does not cause high level 
of mortality, it results in productivity losses 
and induces lameness and its attendant 
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and other equipment and is mainly used in 
large laboratories which can afford to 
purchase and maintain this capability 
(Morrissy et al., 2008). 
Molecular Techniques
In the years since the advent of genetic 
diagnostic techniques nearly two decades 
ago, more than 50 different nucleic acid 
hybridization and various PCR technologies 
have been reported for the diagnosis of FMD 
(Reid et al., 2002). Recently, real time PCR 
methods (Taq Man, molecular beacons, 
Primer-Probe Energy Transfer System) have 
been developed for FMD diagnosis and are 
now the mainstay for FMD genetic diagnosis 
(Reid et al., 2002; Oem et al., 2005; Wieslaw 
et al., 2010). Evaluation of real time PCR 
methods with conventional diagnostics 
(Shaw et al., 2004; Ferris et al., 2006) 
concluded that PCR was generally more 
sensitive and rapid, and is ideal for samples 
which contain low concentrations of virus. 
By introducing nucleic acid extraction and 
pipett ing robot ics ,  together with 
multichannel real time PCR machines, 
diagnostic procedures have become rapid, 
robust and automated but may not be best 
suited to low technology settings. Another 
promising development for the developing 
country laboratories is the one-step, reverse 
transcription loop-mediated amplification 
(RT-LAMP) assay, which enables FMD virus 
to be detected in under 1 hour in a single  
tube without thermal cycling (Dukes et al., 
2006; Jun-Jun et al., 2010).
Antibody Detection Methods.
Liquid Phase Blocking & Competitive 
ELISA   
The FMD liquid phase blocking (LP)-ELISA 
was developed for the detection of FMD 
antibodies because of the drawbacks of the 
conventional virus neutralization tests 
(VNTs), which included slowness of the tests 
(up to 3 days), the use of live virus and cell 
cultures, and the difficulty in reproducing 
results, all which could be countered by the 
LABORATORY DIAGNOSIS
Antigen and Virus Detection
methods Virus Isolation
FMD virus will grow in a wide range of 
primary and continuous in-vitro cell 
cultures. The most sensitive cell culture for 
the isolation of FMDV is primary bovine 
thyroid (BTY) cells (House and House 
1989). Continuous cell lines such as baby 
hamster kidney (BHK), lamb kidney (LK) 
and the pig kidney cell line IB-RS-2 and 
MVPK-1 are also susceptible to FMDV 
infection. The sensitivity of virus isolation 
will depend on the quality and type of cells 
used as well as the quality of the sample
(Morrissy et al., 2008).
Antigen capture ELISA     
The Antigen Capture (AC)-ELISA or 
serotyping ELISA is the test of choice for 
countries endemic with FMD and is the 
recommended test for the detection of FMD 
antigen (OIE, 2008). The FMD AC-ELISA 
provides detection of FMD antigens and 
identification of serotypes in the case of an 
FMD positive sample, and was developed in 
its current form by Roeder and Le Blanc 
Smith, (1987). 
The FMD AC-ELISA replaced the 
complement fixation test for primary FMD 
diagnosis and serotype identification 
because of its increased specificity and 
sensitivity and because it is not affected by 
pro- or anti-complementary factors in the 
test sample (Ferris and Dawson 1988). 
Standard reagents for the FMD AC-ELISA 
are produced at the World Reference 
Laboratory (WRL) for FMD, Pirbright, 
United Kingdom.
Sample quality is important as lesions older 
than 4-5 days have less antigens; however, 
samples unsuitable for virus isolation can be 
tested by ELISA. The ELISA allows high 
throughput testing of samples and is well 
suited to low technology settings. Higher 
throughput can be achieved with robotics 
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inactivation and purification) may induce a 
false positive result in this test. In these 
cases, the history from the field, e.g. about 
p o t e n t i a l  o u t b r e a k s / i n f e c t i o n ,  
identification of vaccine and number of 
vaccinations received, is important for 
correct interpretation of the result.
The use of vaccine for the control of FMD has 
led to the development of a number of 
assays for the detection of NS antibodies to 
discriminate between vaccinated animals 
and those that have been infected. 
Australian Animal Health Laboratory, with 
the support of International Atomic Energy 
Agency, has developed an in-house FMD NS 
3ABC c-ELISA (Morrissy et al., 2007). It uses 
baculovirus expressed 3ABC antigen and a 
competing antibody, which is produced in 
chicken. This ELISA has been used and 
validated in Asia (IAEA, 2007). There are a 
number of commercial ELISA kits available 
including the baculovirus 3ABC expressed 
antigen from CEDI Diagnostics, the E. coli 
3ABC expressed antigen from Bommeli and 
the synthetic 3B antigen from UBI (de 
Bronsvoort et al., 2004). There are 
possibilities of others at different stages of 
development and in-house ELISAs are also 
available in some laboratories. The CEDI 
diagnostics kit and the AAHL kit are both 
competitive ELISAs that can be used for all 
species, whereas the other kits are indirect 
ELISAs with separate kits for ruminants and 
pigs. The CEDI diagnostics kit has been 
found to be the most sensitive and specific 
(Brocchi  et  al . ,  2006).  However, 
comparisons between the kits from CEDI 
and AAHL have shown that both ELISAs 
have similar performance characteristics.
QUALITY ASSURANCE AND QUALITY 
CONTROL
“Quality is fitness for the intended purpose: 
Quality assurance is a system designed to 
assure test facility management of 
compliance with a quality standard, e.g. AS 
ISO 17025-2005” General requirements for 
use of ELISA (Morrissy et al., 2008). The 
FMD LP-ELISA can detect antibodies against 
all seven FMD serotypes using polyclonal 
rabbit and guinea pig IgG antibodies to 
detect residual FMD antigen following in-
vitro incubation of test serum and FMD 
antigen (the “liquid phase”). Result from the 
FMD LP-ELISA indicated high degree of 
correlation with VNT results for post 
infection and vaccinated animals, and it was 
suggested to be a suitable alternative to the 
VNT. It was also suggested that the FMD LP-
ELISA could be used to estimate in-vitro 
protection to FMD challenge (Hamblin et al, 
1986a, 1986b, 1987).
The FMD LP-ELISA is one of the 
recommended ELISA methods for the 
detection of FMD antibodies (OIE, 2008) 
and is the primary test for determining 
vaccine titres, as it is being used in some 
laboratories. Recently, the FMD competitive 
(C)-ELISA has been developed for all seven 
serotypes of FMD in response to the issue of 
FMD LP-ELISA being less conducive to a 
large scale testing and automation. The 
FMD c-ELISA was developed using the same 
reagents as the FMD LP-ELISA, but without 
the “liquid phase” step, allowing a result in 
the same day (4-5 hours). The FMD c-ELISA 
was found to be more robust, sensitive and 
specific than the FMD LP-ELISA, and was 
used in the recent UK FMD outbreak to allow 
rapid screening of serum samples for FMD 
antibodies (Morrissy et al., 2008).
FMD non-structural protein assays
Viral replication in FMD infected animals 
induces an immune response against the 
non-structural (NS) protein of the FMD. The 
response against NS protein is not serotype 
specific and indicates infection with any of 
the seven serotypes. Animals which are not 
infected with FMD but vaccinated normally 
do not develop a detectable antibody 
response against NS protein in the ELISA. 
Nevertheless, repeatedly applied, low 
quality vaccines, (e.g. lack of viral 
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should cover at least the critical range of test 
results to be expected, e.g. strong positive 
control (C++); weak positive control, 
which is slightly above the cut-off (C+); and 
negative control. Analysis of internal quality 
control will give information about intra- 
and inter-assay variations, intra- and inter-
operator variation, day to day variation etc. 
Critical parameters are basic statistics such 
as mean values, standard deviation, co-
efficient of variation, range and upper and 
lower control limits. Results can be charted 
and recorded as Levey-Jennings charts. This 
approach helps to identify trends in assay 
performance and is useful to prompt 
preventive corrective actions or trouble 
shooting. Internal quality control data can 
also be useful to access measurement of 
uncertainty, e.g. continued measurement of 
replicates of internal positive control close 
to the cut-off (De Clercq et al., 2008).
External quality assurance or proficiency 
testing measures the reproducibility of a test 
and i ts  performance in dif ferent 
laboratories. It helps to standardize test 
results for the same test in different 
laboratories (inter-laboratory comparison, 
ring test or external quality assurance) or to 
harmonize test results from different tests in 
different laboratories (proficiency test 
round). Successful and regular participation 
approximately twice a year in external 
quality assurance programmes is an 
essential component of ISO 17025-2005 or 
OIE quality standard requirements, and 
therefore a pre-condition for accreditation 
(De Clercq et al., 2008).
Equipment calibration and maintenance is 
another important part of quality assurance 
because it helps to ensure that tests are 
giving correct results. It is important that 
laboratories have a budget to allow them to 
maintain and calibrate their equipment. In 
summary, quality assurance and quality 
control are crucial elements in a laboratory's 
quality system and need to be well 
the competence of testing and calibration 
laboratories. Quality control is the technical 
realization of the quality assurance concept, 
e.g. calibration, assay validation, precision 
and accuracy of test results. Quality 
assurance and quality control principles are 
crucial requirements to comply with quality 
standards such as ISO 17025-2005 or the 
OIE's “Quality Standard and guidelines for 
Veterinary laboratories: Infectious disease” 
(De Clercq et al., 2008).
The key components of quality assurance 
with regards to FMD diagnosis are:
Paper work/documentation of all tests 
into standard protocols.
Validation data for diagnostic tests 
being used in the laboratory.
Staff training and accreditation.
Internal quality control (IQC) –positive 
and negative controls included in each 
test run.
Analysis and charting to document 
results from IQC controls used in each 
test.
External quality assurance –successful 
participation in proficiency test rounds.
Documentation on all sample collection, 
storage and transport from the field, and 
storage and handling in the laboratory.
Cal ibrat ion of  equipment  and 
calibration records.
Laboratory accreditation to a standard 
e.g. ISO 17025-2005. 
Quality control of the FMD diagnostic tests 
is achieved through a combination of 
internal quality control and external quality 
assurance. Repeatability and reproducibility 
are measurements of precision and results 
are of particular value to monitor the 
validity of test results (De Clercq et al., 
2008).
Internal quality control is useful to measure 
the repeatability of test results in a 
laboratory. Ideally, internal controls should 
be included as replicates in each test run and 
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countries or at the district level.
For FMD serology the LP-ELISA is the test of 
choice in a country where FMD is endemic, 
as it is still the only test validated for post 
vaccination testing. The c-ELISA is used in 
FMD-free countries, and can be used to 
screen sera first as it has greater sensitivity, 
specificity and allows greater throughput. 
The NS-ELISA is used with the structural LP-
ELISA or the c-ELISA to distinguish infected 
animals from vaccinated. The NS-ELISA 
does not identify carrier animals, but rather 
animals that have been infected with FMDV 
in the past. The NS-ELISA can be used to 
indicate disease prevalence or when a 
country is declaring freedom from FMD or in 
animal trading to indicate that animals have 
not been exposed to FMDV. The AC-ELISA is 
used for detection of FMD antigen and is the 
only test able to rapidly determine the 
serotype of an FMD outbreak. PCR is 
important as a confirmation for FMD 
genome and in further characterization of 
FMDV by sequencing. Virus isolation is 
important in producing high-titred stocks of 
FMDV for characterization or for growth of 
samples with low virus titre. Virus isolation 
is used in national or reference laboratories 
due to the high cost of maintaining tissue 
culture.
Overall, the quality of samples submitted to 
the laboratory is of utmost importance in 
achieving precise and accurate results and it 
involves: maintaining a cold chain, 
collection of appropriate samples for 
diagnosis, and collection in the appropriate 
sample collection buffer (i.e. phosphate/-
glycerol for virus isolation and ELISA). 
established to achieve accreditation to 
internationally accepted standards.
CONCLUSION    
Effective diagnosis and control of livestock 
diseases requires a strong animal health 
network where laboratory staff, field 
veterinarians and epidemiologists work 
together. Laboratories contributing to the 
diagnostic network must be able to carry out 
diagnosis with OIE recommended or 
alternative tests within a recognized quality 
assurance  sys tem.  OIE re ference  
laboratories play important roles in 
monitoring disease situation in a country 
and ensuring that continued, updated and 
accurate information is forwarded to OIE. 
This is especially important with TADs, 
zoonotic, and new and emerging diseases 
because of their global threat.
The laboratory network in a country is made 
up of laboratories at different levels of 
standard and capability, from the national 
laboratory down to the province and district 
levels. The diagnostic tests used in these 
laboratories will differ according to their 
respective capabilities.
The national laboratory may have the full 
range of diagnostic tests, which includes 
virus isolation and a molecular capability for 
PCR and sequencing, whereas a provincial 
or district laboratory will most probably 
have low-cost technology. Tests such as 
ELISAs are the most routinely used for FMD 
antibody and antigen detection. ELISAs are 
cheaper to run than virus isolation and PCR 
but reagents and equipment are still 
expensive for laboratories in poorer 
the detection of antibodies to the non-
structural proteins of foot-and-mouth 
disease virus. Vaccine 24, 6966-6979.
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